Multicenter analysis of outcomes in blastic plasmacytoid dendritic cell neoplasm offers a pretargeted therapy benchmark

Taylor, J; Haddadin, M; Upadhyay, VA; Grussie, E; Mehta-Shah, N; Brunner, AM; Louissaint, A; Lovitch, SB; Dogan, A; Fathi, AT; Stone, RM; Tallman, MS; Rampal, RK; Neuberg, DS; Stevenson, KE; Horwitz, SM; Lane, AA

Lane, AA (reprint author), Dana Farber Canc Inst, 450 Brookline Ave,Mayer 413, Boston, MA 02215 USA.

BLOOD, 2019; 134 (8): 678

Abstract

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an uncommon hematologic malignancy with poor outcomes. Existing data on the clinical behavior ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索